Similar articles for PMID: 33941597

Year	Number of Results
2009	8
2010	6
2011	3
2012	9
2013	13
2014	6
2015	5
2016	13
2017	15
2018	11
2019	3
2020	4
2021	11
2022	12
2023	5
2024	0

1

Gilligan T. Gilligan T. Cleve Clin J Med. 2021 May 3;88(5):262. doi: 10.3949/ccjm.88c.05004. Cleve Clin J Med. 2021. PMID: 33941597 Free article. No abstract available.

2

In Reply: Prostate cancer screening.

Sooriakumaran P. Sooriakumaran P. Cleve Clin J Med. 2021 May 3;88(5):261. doi: 10.3949/ccjm.88c.05003. Cleve Clin J Med. 2021. PMID: 33941596 Free article. No abstract available.

3

Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?

Jackson BR. Jackson BR. Arch Pathol Lab Med. 2013 Mar;137(3):308-9. doi: 10.5858/arpa.2012-0241-ED. Epub 2012 Jul 16. Arch Pathol Lab Med. 2013. PMID: 22799565 Free article. No abstract available.

4

Prostate Cancer Screening at US Cancer Centers-Reply.

Marti JL, Lee AYJ, Koh ES. Marti JL, et al. JAMA Intern Med. 2022 Sep 1;182(9):1008-1009. doi: 10.1001/jamainternmed.2022.2459. JAMA Intern Med. 2022. PMID: 35789361 No abstract available.

5

[Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].

Borkowetz A. Borkowetz A. Urologe A. 2019 Aug;58(8):925-928. doi: 10.1007/s00120-019-0990-6. Urologe A. 2019. PMID: 31240375 German. No abstract available.

6

Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Taneja SS. Taneja SS. J Urol. 2016 Feb;195(2):350-1. doi: 10.1016/j.juro.2015.10.166. Epub 2015 Nov 4. J Urol. 2016. PMID: 26852972 No abstract available.

7

Alternative prostate cancer screening strategies.

Labrecque M, Aprikian A. Labrecque M, et al. Ann Intern Med. 2013 May 21;158(10):778. doi: 10.7326/0003-4819-158-10-201305210-00019. Ann Intern Med. 2013. PMID: 23689773 No abstract available.

8

Alternative prostate cancer screening strategies--in response.

Gulati R, Etzioni R. Gulati R, et al. Ann Intern Med. 2013 May 21;158(10):778-9. doi: 10.7326/0003-4819-158-10-201305210-00020. Ann Intern Med. 2013. PMID: 23689774 No abstract available.

9

Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.

Klotz L. Klotz L. Oncology (Williston Park). 2016 Aug;30(8):694, 764. Oncology (Williston Park). 2016. PMID: 27528237 Free article. No abstract available.

10

Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time.

Scosyrev E, Messing EM. Scosyrev E, et al. Cancer. 2013 Mar 1;119(5):1113-4. doi: 10.1002/cncr.27875. Epub 2012 Oct 23. Cancer. 2013. PMID: 23097014 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year